Kura Oncology Inc logo

Kura Oncology Inc

$ 12.57 -0.58 (-4.41%) 10:08 PM EST
P/E:
At Loss
P/B:
2.00
Market Cap:
$ 858.53M
Enterprise V:
$ 475.75M
Volume:
299.58K
Avg Vol (2M):
924.56K
Also Trade In:
Volume:
299.58K
Market Cap $:
858.53M
PE Ratio:
At Loss
Avg Vol (2-Month):
924.56K
Enterprise Value $:
475.75M
PB Ratio:
2.00

Business Description

Description
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 79.45
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 20.06
9-Day RSI 33.36
14-Day RSI 39.82
6-1 Month Momentum % -21.69
12-1 Month Momentum % -4.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.64
Quick Ratio 17.64
Cash Ratio 17.29

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.4

Financials (Next Earnings Date:2023-02-24 Est.)

KURA's 30-Y Financials

How Kura Oncology Inc (KURA) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KURA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.03
Beta 0.74
Volatility % 57.32
14-Day RSI 39.82
14-Day ATR ($) 0.731984
20-Day SMA ($) 13.679
12-1 Month Momentum % -4.1
52-Week Range ($) 10.41 - 19.93
Shares Outstanding (Mil) 68.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kura Oncology Inc Filings

Document Form Filing Date
No Filing Data

Kura Oncology Inc Stock Events

Event Date Price($)
No Event Data

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1